How PGEU Operates
The PGEU has a Secretariat located in Brussels with a staff of five people who coordinates the daily work of the association. The PGEU holds a General Assembly two times per year (June and November) to which all members and observer members are invited to participate. PGEU holds an Annual Symposium which takes place immediately after or before the June General Assembly. The PGEU has a management board known as the Executive Committee whose members are representatives of PGEU member organisations.
The Presidency of the PGEU changes on an annual basis by the way of a rotation system among members. To facilitate the work of the PGEU in giving advice and formulating proposals in many different policy areas relevant to community pharmacy and public health, a number of PGEU Working Groups have been established.
The General Assembly is the supreme body of the association which decides on all important matters including PGEU policy decisions and the annual budget. The General Assembly meets two times per year and all ordinary members and observer members delegations attend. Policy proposals are developed by the Working Groups in collaboration with the Secretariat, and the Executive Committee presents policy proposals to the General Assembly with its recommendations for action.
PGEU Annual Conference
PGEU holds an annual conference every year the day before/after the June General Assembly. The annual conference features expert speakers from the world of pharmacy, the European institutions, national authorities, academia and patient groups.
Executive Committee :
- Meets on a monthly basis.
- Assists the Secretary General in managing the association and implementing the resolutions of the General Assembly.
- Examines policy proposals developed by the WorkingGroups in collaboration with the Secretariat and presents the proposals and the Committee's recommendations for action to the General Assembly.
- The chair of the Executive Committee is the President.
Currently the Executive Committee consists of 9 members. EXCO Members 2021 : Austria - Belgium - Cyprus - Czech Republic - Finland - France - Germany - Italy - Slovakia.
The President is elected by the national delegations.
President : Alain Delgutte (France) is PGEU President for 2021.
Mr Delgutte is a member of the National Council of the French Chamber of Pharmacists. A practicing pharmacy owner in Nevers, Burgundy, Alain Delgutte holds a pharmacy diploma, as well as a Master’s degree in business management and orthopaedics qualifications.
Vice President : Mathias Arnold (Germany) is PGEU Vice-President for 2021.
Mr Arnold is currently ABDA Vice-President and a practicing pharmacist in his Lilien-Apotheke in Halle in Germany. He holds a degree in pharmaceutical studies from the University of Halle and has been certified as pharmacist since 1988.
The PGEU has to give advice and formulate proposals in many different policy areas relevant to community pharmacy and public health. To facilitate this work, the Executive Committee or the General Assembly can propose the establishment of a working group to deal with specific issues. The working group members are experts appointed by PGEU members. The working groups provide additional technical expertise to the Secretariat in developing policy proposals, which are then presented by the Executive Committee to the General Assembly for approval. The following working groups are currently active:
- Advisory Working Group (AWG) : The AWG is the main consultative body of the PGEU, covering a wide range of policy areas and is currently the key forum for discussion and development of PGEU policy papers.
- European Pharmacists' Professional Forum (EPPF) : The European Pharmacists' Professional Forum deals with professional issues, including issues related to mobility of pharmacists, mutual recognition of professional qualifications, education and training of pharmacists, patient safety, pharmacy practice, collaboration with other stakeholders, etc.
- Economics Working Group (EWG): The EWG deals with current economic issues and with latest developments in health policy and health economics affecting community pharmacies. These include trends related to fiscal sustainability of health systems, strengthening of primary care services, pricing and reimbursement policies, health technology assessment, digitalization in healthcare.